1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 7,000 Shares

November 13, 2012 | About:

CEO of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Jean Jacques Bienaime sells 7,000 shares of BMRN on 11/09/2012 at an average price of $47.62 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $5.94 billion; its shares were traded at around $48.44 with and P/S ratio of 13.5.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 11/09/2012 at the average price of 47.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 1.72% since.
  • CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 10/31/2012 at the average price of 37.96. Jean Jacques Bienaime owns at least 174,691 shares after this. The price of the stock has increased by 27.61% since.
  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 10/22/2012 at the average price of 41.86. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 15.72% since.
  • CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 10/19/2012 at the average price of 42.72. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 13.39% since.
  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 10/12/2012 at the average price of 41.32. Jean Jacques Bienaime owns at least 177,691 shares after this. The price of the stock has increased by 17.23% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • Director Elaine J Heron sold 135,000 shares of BMRN stock on 11/09/2012 at the average price of 46.79. Elaine J Heron owns at least 15,900 shares after this. The price of the stock has increased by 3.53% since.
  • Director Alan Lewis sold 15,000 shares of BMRN stock on 11/07/2012 at the average price of 46.8. Alan Lewis owns at least 15,900 shares after this. The price of the stock has increased by 3.5% since.
  • EVP, Chief Medical Officer Henry J Fuchs sold 10,000 shares of BMRN stock on 11/05/2012 at the average price of 46. Henry J Fuchs owns at least 52,277 shares after this. The price of the stock has increased by 5.3% since.
  • EVP, Technical Operations Robert Baffi sold 60,000 shares of BMRN stock on 11/05/2012 at the average price of 47.33. Robert Baffi owns at least 100,413 shares after this. The price of the stock has increased by 2.35% since.
  • VP, Corporate Controller Brian Mueller sold 8,000 shares of BMRN stock on 11/05/2012 at the average price of 47.03. Brian Mueller owns at least 15,340 shares after this. The price of the stock has increased by 3% since.


For the complete insider trading history of BMRN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK